Skip to main content
SCYNEXIS INC logo

SCYNEXIS INC — Investor Relations & Filings

Ticker · SCYX ISIN · US8112922005 LEI · 529900XBHFGMNTU70154 US Manufacturing
Filings indexed 684 across all filing types
Latest filing 2014-10-02 Director's Dealing
Country US United States of America
Listing US SCYX

About SCYNEXIS INC

https://www.scynexis.com/

SCYNEXIS, Inc. is a biotechnology company focused on the discovery and development of novel anti-infectives to overcome difficult-to-treat and drug-resistant fungal infections. The company is pioneering a new class of broad-spectrum antifungal agents called 'fungerps,' which are triterpenoid-based compounds. These agents are being developed in both oral and intravenous formulations to treat a range of serious, invasive, and life-threatening fungal diseases, particularly those encountered in hospital environments. SCYNEXIS aims to address the significant global health threat of antifungal resistance by providing innovative therapeutic options where existing treatments are limited or ineffective. The company's development pipeline includes second-generation fungerp candidates.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2014-10-02 English
FORM 4
Director's Dealing
2014-10-02 English
FORM 4
Director's Dealing
2014-10-02 English
FORM 4
Director's Dealing
2014-10-02 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated September 11, 2014, reporting the submission of matters to a vote of security holders at a Special Meeting. It details the voting results on proposals related to equity incentive plans and the ratification of the independent auditor. The content is focused on the official results of shareholder votes, which aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and contains detailed vote counts, confirming it is the voting results announcement itself, not a report or proxy solicitation material.
2014-09-16 English
FORM 10-Q
Interim / Quarterly Report Q2 2014
2014-08-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.